CBD & Cannabinoids 100% Legal in France – Flowers, Resins, Oils at Affordable Prices | Fast Delivery
Discover the world of Vibe City , your CBD shop dedicated to lovers of quality hemp. Browse our latest arrivals and explore a carefully curated selection of CBD flowers, resins and hash, concentrated oils and wellness infusions , chosen to showcase the full natural potential of hemp.
Each product is selected for its quality, aromatic profile, and compliance with European legislation. With Vibe City , enjoy legal, authentic, and carefully selected CBD to support your daily well-being.
Controlled quality, transparent traceability and expertise at your service: take advantage of a wide selection of high-performance CBD products at the best value for money.
Order with confidence and discover a simple, secure and fast shopping experience.
Discover our selection of potent CBD flowers , grown using various methods: indoor, greenhouse, and outdoor . Each variety is chosen for its aromatic profile, quality, and cannabinoid content.
For those who love cheap CBD , also explore our Small Bud , made up of small CBD flowers offering excellent value for money, without compromising on flavors or effects.
Discover our selection of premium CBD resins and hash , crafted from carefully cultivated hemp rich in cannabinoids. Our resins stand out for their varied textures, intense aromas, and authentic terpene profiles , offering a complete experience for hemp concentrate enthusiasts.
Whether you are looking for a powerful CBD hash, a traditional resin or a cannabidiol-rich concentrate , Vibe City offers products that comply with European legislation (THC < 0.3%), selected for their quality and aromatic intensity.
Discover our selection of next-generation cannabinoids , designed to offer diverse experiences to hemp enthusiasts and fans of innovative extracts. At Vibe City , we offer products made from legal cannabinoids, selected for their quality, purity, and compliance with European regulations.
Whether you are curious to discover the latest innovations in the hemp market or looking for more concentrated extracts, our range of cannabinoids allows you to explore new possibilities while benefiting from controlled and carefully selected products.
Discover our selection of hemp and CBD-based cosmetics , specially designed to hydrate, soothe, and protect your skin every day . Rich in natural active ingredients, these products harness the properties of hemp to provide comfort, suppleness, and skin balance , while respecting even the most sensitive skin. Creams, balms, gels, or oils: each product easily integrates into your beauty routine.
Our formulas combine CBD, CBG, and plant extracts for comprehensive action, ideal for combating external aggressors such as cold, pollution, and stress. Prized for their pleasant texture and effectiveness, these cosmetics help you achieve soft, nourished, and visibly healthier skin , thanks to a natural and modern approach to skincare.
Discover testimonials and feedback from our customers on our CBD flowers, resins, oils and products.
Hemp is a fascinating plant that has been part of humanity's life for thousands of years. Used by ancient civilizations for its strong fibers, nutritious seeds, and oils, it already held an important place in Chinese and Egyptian cultures. Textiles, food, traditional uses: hemp was recognized for its versatility and natural richness.
Today, this ancestral heritage continues through CBD, a compound naturally present in the hemp plant. While its uses have evolved, its origin remains the same: a plant cultivated for millennia for its numerous properties.
From a scientific standpoint, cannabidiol was first isolated in 1940 by American researcher Roger Adams and his team. A few years later, in 1963, researchers Raphael Mechoulam and Yechiel Shvo succeeded in precisely determining its chemical structure. These discoveries marked the starting point of modern research on CBD, allowing for a better understanding of its mechanisms and distinguishing it from other cannabinoids found in hemp.
Today, interest in CBD stems from both this age-old tradition and contemporary scientific advancements. It embodies a convergence of ancient know-how and modern innovation.
CBD, or cannabidiol, is one of the many cannabinoids naturally present in the hemp plant. This plant contains several active compounds such as THC, CBN, and CBG. Cannabidiol is one of them.
Unlike THC, CBD has no psychotropic effects. It does not cause euphoria or altered perception. This fundamental difference is what allows its legal sale in many European countries today, provided that regulatory THC limits are respected.
In some varieties of industrial hemp, CBD can represent a significant proportion of the cannabinoids present. Over the years, it has become a major player in the natural wellness sector.
CBD interacts with the endocannabinoid system, a biological system present in humans and animals. This network plays a regulatory role in many functions: mood, sleep, appetite, stress management, and even the perception of certain bodily sensations. This interaction explains the growing interest in this molecule.
If CBD is enjoying increasing success, it is partly because it is being studied for its potential properties, without presenting the psychotropic effects associated with THC.
Scientific research continues to explore its mechanisms of action and its interaction with various biological systems. At the same time, a growing number of consumers are interested in natural alternatives as part of a holistic wellness approach.
CBD has an important characteristic: it is lipophilic, meaning it dissolves in fats. This property influences its formulation, particularly in oils, and explains its natural presence in certain biological environments.
When used appropriately and in accordance with regulations, CBD is now part of a quest for balance and relaxation in daily life. Its appeal lies in its natural composition, its legality, and the variety of formats available.
CBD (cannabidiol) is generating increasing interest in France and Europe. Naturally present in hemp ( Cannabis sativa L. ), it is now widely used in the form of CBD flowers, CBD oils, resins, capsules or cosmetics .
Before going any further, an essential point: CBD is not a medicine . It does not replace any medical treatment and should not be considered as such. Scientific research is progressing rapidly, but some effects still need to be confirmed by large-scale clinical trials.
That being said, numerous studies suggest that cannabidiol could play an interesting role in overall well-being , particularly through its interaction with the endocannabinoid system , a biological system involved in the regulation of many physiological functions.
Here is a structured overview of the main potential benefits of CBD.
One of the most studied areas concerns the use of CBD to relieve pain .
Research indicates that cannabidiol may act indirectly on receptors involved in pain perception within the nervous system. It interacts in particular with CB1 and CB2 receptors of the endocannabinoid system, as well as with other biological targets linked to inflammation.
CBD is particularly studied for:
Chronic pain
Inflammatory pain
Joint pain
Muscle tension
Its anti-inflammatory potential would partly explain this effect. By modulating certain immune responses, it could help reduce the inflammation responsible for many persistent pains.
More and more consumers are choosing broad-spectrum or full-spectrum CBD oils , as well as concentrated CBD resins , to complement their wellness routine.
CBD is also being studied for its potential effects on stress and anxiety .
Several scientific studies suggest that it could interact with serotonin receptors (notably the 5-HT1A receptor), which are involved in regulating mood and stress responses.
This interaction could contribute to:
Reduce the feeling of stress
Alleviating certain forms of anxiety
Promote a state of mental relaxation
Improve emotional stability
It is important to note that studies on depression and anxiety disorders are still ongoing. CBD should not be used as a substitute for prescribed medical treatment. However, its non-psychoactive profile (THC < 0.3% in legal products in France) makes it an increasingly explored option for everyday well-being.
Sleep is closely linked to stress, anxiety, and hormonal balance. By promoting relaxation, CBD could indirectly improve sleep quality .
Some people report:
Falling asleep faster
Fewer nighttime awakenings
A feeling of deeper rest
Better recovery upon waking
Cannabidiol does not act like a conventional sleeping pill. Rather, it appears to contribute to a better overall balance, thus facilitating natural sleep onset.
Combined with ingredients like melatonin , some products may enhance this effect. However, every body reacts differently, and it is recommended to start with a gradually increasing dosage.
CBD is also present in many cosmetics and dermatological treatments .
Thanks to its potential anti-inflammatory and sebum-regulating properties, it could be useful for certain skin problems such as:
Acne
Eczema
Psoriasis
Redness and irritation
Applied as a cream, balm, or serum, cannabidiol acts locally. It may help soothe skin inflammation and regulate sebum production, two key factors in dermatological disorders.
Topical CBD products are increasingly appealing to consumers looking for natural alternatives to care for their skin.
The neuroprotective potential of CBD is the subject of extensive studies. Research is exploring its benefits in certain neurological conditions such as:
Epilepsy
Multiple sclerosis
Parkinson's disease
Alzheimer's disease
In the case of certain forms of severe epilepsy, a cannabidiol-based drug has already been authorized in several countries, illustrating the seriousness of the research in this field.
Scientists are particularly interested in CBD's ability to:
Modulating neuronal activity
Reduce brain inflammation
Protecting nerve cells
However, these applications fall under a strict medical framework and require specialized monitoring.
The digestive system also contains receptors for the endocannabinoid system. This explains why CBD may have an influence on:
Appetite
Nausea
Digestive discomfort
Mild gastrointestinal disorders
Some studies suggest that cannabidiol may help regulate intestinal inflammation and support digestive balance.
People experiencing discomfort related to stress or certain medications are particularly interested in this aspect. Here again, medical advice remains essential in the event of a diagnosed condition.
Preliminary research indicates that CBD may have an impact on blood pressure and oxidative stress .
Since chronic stress is a cardiovascular risk factor, the potential role of cannabidiol in stress regulation could indirectly benefit the cardiovascular system.
Some studies have observed:
A temporary decrease in blood pressure in stressful situations
A reduction in oxidative stress
A relaxing effect on blood vessels
However, these results need to be confirmed by larger clinical trials before any specific recommendation can be made.
Many athletes now use CBD to support their recovery after exercise.
After intense training, the body experiences micro-tears in the muscles and natural inflammation. Cannabidiol may help to:
Reduce post-exercise inflammation
Relieving muscle aches
Promote muscle relaxation
Improving the quality of rest
By optimizing recovery and sleep, CBD could indirectly support overall performance.
Its non-psychoactive status makes it a product compatible with a sports routine, provided that applicable legislation and anti-doping regulations are respected.
Vibe City is a CBD shop specializing in the sale of legal CBD in France (THC < 0.3%) and new generation cannabinoids compliant with European regulations.
Our mission: to offer rigorously selected CBD flowers, resins, oils and extracts , with an emphasis on quality, traceability and scientific transparency.
The CBD market is evolving rapidly. To guarantee a secure purchase, we apply strict criteria:
Selection of varieties authorized in Europe
THC level strictly less than 0.3%
Independent laboratory analysis
Batch traceability
Actual stock based in France
Every product available on Vibe City meets precise quality and compliance standards. We prioritize producers recognized in France and Europe.
Are you looking for a reliable website to buy CBD in France ?
At Vibe City, we offer:
👉 Premium CBD Flowers (indoor, greenhouse, outdoor)
👉 Concentrated CBD Resins & Hash
👉 Full Spectrum and Broad Spectrum CBD Oils
👉 Legally Available Innovative Cannabinoids
Our catalogue is structured to allow you to easily compare profiles, concentrations and uses.
CBD (cannabidiol) is a non-psychoactive cannabinoid derived from hemp ( Cannabis sativa L. ).
It interacts with the endocannabinoid system , which is involved in physiological balance (homeostasis).
Unlike THC, CBD does not produce a euphoric effect. In France, only products that comply with the legal limit are authorized for sale.
We provide:
Educational guides
Detailed fact sheets
Clear regulatory information
Responsible usage advice
➡️ Read our complete guides on CBD
Shipping from France
Neutral and discreet packaging
Tracked delivery 24/72h
Express option
Secure 3D Secure payment
Your privacy and the security of your data are our top priority.
Vibe City delivers to more than 20 European countries, including:
France
Germany
Belgium
Spain
Italy
Netherlands
Switzerland
Portugal
Austria
Sweden
➡️ See the full list of countries served
We regularly publish detailed articles on:
The differences between CBD and THC
The new cannabinoids
European regulations
The quality criteria for a good CBD
Our goal: to help you make an informed purchase.
Looking for legal CBD in France , of superior quality and laboratory certified? Welcome to the world of Vibe City CBD, your online CBD shop specializing in the sale of CBD flowers, CBD resins, CBD oils and new generation cannabinoids, 100% compliant with French legislation (< 0.3% THC).
Here, every product is carefully selected. Our premium CBD flowers come from controlled cultivation, are rich in natural terpenes, and are analyzed in an independent laboratory to guarantee purity, cannabinoid levels, and regulatory compliance. Our legal CBD resins and hash offer powerful aromatic profiles and a refined texture to satisfy even the most discerning enthusiasts. Our full-spectrum and broad-spectrum CBD oils are formulated to ensure optimal bioavailability and complete traceability.
Vibe City CBD is much more than just an online CBD shop. It's a carefully curated selection of cannabinoids legal in France , including innovative molecules that strictly comply with European regulations. All our products are inspected, tested, and accompanied by accessible certificates of analysis.
You will benefit from:
✔ Laboratory-certified legal CBD
✔ THC content less than 0.3%
✔ Fast delivery in France
✔ Secure payment
✔ Responsive customer service
Our goal is simple: to offer you the best legal CBD in France , with total transparency on the origin, composition and quality of each product.
Whether you are a fan of potent CBD flowers , a devotee of concentrated resins , or looking for a premium CBD oil , you will find here a complete range to suit your needs.
Enter the Vibe City CBD universe and discover a new benchmark for online CBD in France .
In a rapidly expanding CBD market, not all products are created equal. At Vibe City CBD, quality is not based on marketing promises, but on a rigorous process of selection, analysis, and regulatory compliance.
Each product offered in our online CBD shop undergoes independent laboratory testing . These tests verify:
The exact level of CBD and cannabinoids present
Compliance with the legal THC threshold of less than 0.3%
The absence of heavy metals
The absence of pesticides
The absence of residual solvents
This requirement guarantees that CBD is legal in France and fully compliant with European regulations , while ensuring safety and transparency for you.
Our CBD flowers, resins, and oils come from crops grown under authorization within the European Union. The varieties used are listed in the official catalogue of authorized hemp varieties, in accordance with current regulations.
Traceability is complete, from cultivation to sale. This means that every CBD product sold in our shop can be identified, checked, and substantiated in the event of an audit.
Buying legal CBD in France should never be a gray area. That's why we prioritize a responsible and transparent approach.
Regulations, comparisons, focus on molecules, 2026 trends and practical advice for buying legal CBD with confidence.
The question often arises: can you drive after consuming legal CBD in France?
The answer deserves a clear explanation, as it rests on an essential distinction between the legality of the product and road traffic regulations.
CBD (cannabidiol) is not classified as a narcotic in France. It is authorized for sale when its THC content is below the regulatory threshold of 0.3%. However, THC (delta-9-tetrahydrocannabinol) remains a substance classified as a narcotic, even in trace amounts.
However, some CBD products, even those perfectly legal and compliant with European regulations, may contain residual traces of THC. These residues, although small and permitted in a commercial context, can be detected during a roadside check.
Roadside checks in France are mainly based on saliva tests designed to detect the presence of substances classified as narcotics, including THC.
It is important to understand a fundamental point:
French road legislation does not operate on a tolerance threshold for THC.
According to Article L.235-1 of the Highway Code, the offence of driving after using narcotics is constituted as soon as a substance classified as a narcotic is detected in the body of the driver.
In other words:
It is not necessary to reach a certain rate.
There is no minimum permitted threshold.
The mere presence of THC is sufficient to constitute the offence.
This means that a legal CBD consumer can, in theory, test positive for THC if residual traces are detected in their saliva or blood.
The criminal chamber of the Court of Cassation confirmed this interpretation in a ruling issued on June 21, 2023.
The highest court clarified that:
"The authorization to market certain cannabis derivatives, whose delta-9-tetrahydrocannabinol content does not exceed 0.30%, has no bearing on the criminalization of driving under the influence of narcotics […] regardless of the dose ingested."
In simple terms:
Even if the product consumed is legal and complies with CBD regulations, this does not automatically protect the driver in the event of THC detection during a check.
The legal logic is clear:
CBD trade regulation and road traffic regulation pursue two distinct objectives.
The first one regulates the placing on the market.
The second aims at road safety.
If THC is detected during a roadside check, the penalties stipulated by the Highway Code are severe:
6 points deducted from the driving licence
Fine of up to €4,500
Suspension or cancellation of the license
A prison sentence of up to 2 years
Vehicle immobilization
These sanctions apply regardless of whether the THC comes from a legal CBD product or an illegal product.
From a scientific perspective, CBD is not considered psychoactive in the same way as THC. It does not produce a euphoric effect or significantly impair cognitive abilities in the majority of users.
However :
Some people may experience mild drowsiness.
Full spectrum products contain traces of THC.
Individual sensitivity varies.
It is therefore recommended to avoid driving immediately after consumption, especially during the first uses or in case of high concentration.
Not all CBD products present the same potential risk of detection.
Contains all the cannabinoids of the plant, including legal traces of THC (< 0.3%).
➡ Theoretical higher risk of detection.
Contains no detectable THC (or only trace amounts).
➡ Reduced risk, but never completely zero depending on the sensitivity of the tests.
Pure CBD without other cannabinoids.
➡ The risk associated with THC is generally non-existent if the product is perfectly purified.
It is therefore essential to check the nature of the product consumed and to consult the certificates of analysis.
In the event of a positive saliva test, a confirmatory blood test is generally performed.
However, current case law remains strict: the mere presence of THC is sufficient to constitute an offense.
The fact of having consumed a legal product does not, in itself, constitute an automatic exemption.
If you consume legal CBD in France and you need to drive:
Avoid consuming any food or drink shortly before driving
Opt for products without THC (broad spectrum or isolate)
Keep the certificates of analysis for the products purchased
Stay informed about legislative developments
Caution remains the best approach.
✔ CBD is legal in France if it contains less than 0.3% THC.
✔ Driving under the influence of drugs is punishable even with the mere presence of THC.
✔ A legal product can still result in a positive test.
✔ There is no legal limit for THC while driving.
Current regulations therefore require particular vigilance from CBD consumers who wish to drive.
Official source: drogues.gouv.fr
The question of daily CBD consumption frequently arises among users seeking a long-lasting and stable effect. Cannabidiol (CBD), a non-psychoactive molecule derived from hemp (Cannabis sativa L.), is now widely used in France in the form of oils, flowers, resins, capsules, and infusions.
But is it really beneficial to take CBD every day?
The answer depends on several factors: product quality, dosage, individual profile, and potential drug interactions.
CBD interacts with the endocannabinoid system (ECS), a biological network involved in regulating many functions: sleep, stress, inflammation, mood, appetite, and overall balance of the body.
Unlike THC, CBD does not produce a euphoric effect. Its action is more modulating than stimulating.
Daily consumption can help:
A gradual regulation of certain imbalances
A stability of the effects felt
The body adapts better to the molecule
A continuous action on the endocannabinoid system
Some people experience more consistent effects when they take it regularly rather than occasionally.
Available scientific data indicates that CBD does not have any identified addictive potential. The World Health Organization (WHO) has also emphasized that CBD does not appear to cause dependence or abuse in humans.
This means that daily consumption, in itself, is not associated with the classic mechanisms of addiction observed with certain psychoactive substances.
However, any substance consumed regularly must be used with discernment and responsibility.
Not all products available on the market offer the same level of quality.
If you are considering taking it daily, it is essential to choose:
CBD is legal in France (< 0.3% THC)
A product certified by an independent laboratory
An absence of pesticides and heavy metals
Complete traceability
A concentration tailored to your profile
Regular consumption implies increased vigilance regarding the composition and purity of the product used.
CBD is metabolized by the liver, notably via cytochrome P450 enzymes. This enzyme system is also involved in the metabolism of many drugs.
This means that CBD may interact with certain treatments, including:
Anticoagulants
Antidepressants
Antiepileptics
Cardiovascular medications
Immunosuppressants
These interactions can alter the effectiveness or concentration of the drug in the body.
Therefore, it is strongly recommended to consult a healthcare professional if you are undergoing medical treatment before adopting a daily consumption of CBD.
There is no universal dosage applicable to everyone. The response to CBD varies depending on:
Body weight
Individual sensitivity
Metabolism
The desired objective
The concentration of the product
In general, it is advisable to:
Start with a low dose
Observe the effects for several days
Adjust gradually if necessary
Avoid unnecessary overdoses
Regularity can sometimes be more important than quantity.
CBD is generally well tolerated, but some mild side effects may occur, including:
Fatigue
Dry mouth
Mild digestive problems
Temporary drop in blood pressure
These effects are generally moderate and related to an excessive dosage.
Controlled daily consumption, adapted to individual profiles, greatly limits these risks.
Often chosen for specific and temporary needs.
May be suitable for those seeking stability in the effects felt or a preventive and continuous approach.
The important thing is to regularly assess the relevance of consumption and to avoid any excessive automation.
No. Certain situations require particular caution:
Pregnancy and breastfeeding
Liver diseases
Complex drug treatments
Specific medical history
In these cases, medical advice is essential.
✔ CBD can be consumed daily by some users
✔ It has no known addictive potential
✔ Product quality is essential
✔ Drug interactions must be considered
✔ Medical advice is recommended if undergoing treatment
Regular CBD consumption should always be part of a responsible, informed approach adapted to your personal situation.
Confusion between CBD and cannabis is common, as both terms refer to the same plant of origin: Cannabis sativa L. However, from a legal, chemical and physiological point of view, the distinction is essential.
To fully understand the difference between CBD and cannabis, it is first necessary to distinguish between the plant, its active molecules and their legal status in France.
Cannabis is a plant that naturally contains over a hundred cannabinoids. Among them, the two best known are:
THC (tetrahydrocannabinol)
CBD (cannabidiol)
These two molecules coexist in the plant, but their effects and legal status differ radically.
Tetrahydrocannabinol (THC) is the main psychoactive substance in cannabis. It is responsible for the euphoric effects, sensory alterations, and perceptual changes associated with recreational cannabis use.
THC acts primarily on CB1 receptors of the endocannabinoid system, located largely in the brain. This interaction explains:
The sensations of euphoria
Changes in perception
Cognitive impairments
The effects on memory and coordination
In France, THC is classified as a narcotic substance.
Its consumption, possession, and sale are prohibited.
Recreational products containing THC are therefore illegal in France.
Cannabidiol (CBD), although derived from the same plant, has a very different pharmacological profile.
CBD:
Does not induce a euphoric effect
Does not cause any major alteration of perception
Not classified as a narcotic in France
It is authorized for sale when it complies with the legal THC threshold (< 0.3%)
Its mechanism of action is also distinct. Unlike THC, CBD does not directly stimulate CB1 receptors in a significant way. Rather, it acts as a modulator of the endocannabinoid system and also interacts with other biological systems, including:
The serotonergic system
TRPV1 receptors
Certain mechanisms related to the regulation of stress and inflammation
This interaction with the serotonergic system partly explains the calming effects reported by some users, as serotonin is involved in the regulation of mood, sleep and pain.
The legal distinction is clear:
Cannabis containing THC is prohibited.
CBD is permitted, provided that the final product contains less than 0.3% THC and comes from authorized hemp varieties.
CBD is therefore legal in France when it meets these criteria.
It is sold in:
Specialty shops
Some pharmacies
E-commerce websites
Stores dedicated to hemp
However, the legality of CBD does not change the status of THC, which remains strictly regulated.
Yes, in some cases.
So-called “full spectrum” products contain all the cannabinoids present in the plant, including legal traces of THC.
This means that:
The THC content is below the regulatory threshold
Traces may nevertheless be detectable
Only an independent laboratory analysis can guarantee the conformity of a product.
It is therefore essential to check:
Certificates of analysis
The exact THC level
The origin of hemp
The extraction process
A quality CBD product must be purified and tested to avoid any significant presence of THC.
The term “psychoactive” is often misleading.
CBD is not psychoactive in the sense that it does not cause euphoria or altered consciousness like THC.
However, it can act on the central nervous system via indirect mechanisms, notably through its interaction with serotonin. This may explain some of the reported relaxing or calming effects.
It is therefore more accurate to say that CBD is not psychotropic and is not classified as a narcotic.
Seeking a euphoric effect
Use prohibited in France
Substance classified as a narcotic
Wellness use
Products authorized under certain conditions
Not classified as a narcotic
The intended use therefore differs radically.
Several factors contribute to this confusion:
Identical botanical origin
The visual appearance of the flowers is sometimes similar
Related terminology
Traces of THC may be present in some products
However, the chemical and legal distinction remains clear.
✔ Cannabis is a plant containing several active molecules.
✔ THC is psychoactive and illegal in France.
✔ CBD is not classified as a narcotic.
✔ CBD products must contain less than 0.3% THC.
✔ Quality and laboratory analysis are essential.
Understanding the difference between CBD and cannabis helps avoid legal confusion and promotes responsible consumption in accordance with French regulations.
Source: ameli.fr (Health Insurance)
Cannabidiol (CBD) is now widely used in France in the form of oils, flowers, resins, capsules, or infusions. Although it is not classified as a narcotic and has a generally favorable safety profile, it remains a biologically active substance.
Like any active molecule acting on the body, CBD can cause drug interactions, adverse effects and require special precautions depending on the individual's profile.
It is therefore essential to adopt a responsible and informed approach.
CBD is primarily metabolized by the liver via the cytochrome P450 enzyme system. This system is also involved in the metabolism of many drugs.
This means that CBD can alter the concentration of certain treatments in the blood, either by increasing their levels or by slowing their elimination.
Certain situations require particular caution.
In individuals with liver dysfunction, the body's ability to metabolize CBD may be impaired. Because CBD is metabolized in the liver, greater accumulation may occur, increasing the risk of side effects.
Medical monitoring is then recommended.
CBD may interact with certain medications used to treat epilepsy, including:
Valproate
Clobazam
Cannabidiol itself possesses moderate sedative properties. Combining it with other sedative medications may increase drowsiness.
In some cases, changes in plasma concentrations may be observed. Medical monitoring is essential if antiepileptic treatment is underway.
Everolimus, used particularly in oncology or transplantation, may have its absorption altered in the presence of CBD.
In some people, cannabidiol can increase the blood concentration of this drug, which exposes them to a risk of overdose.
In this context, the use of CBD must absolutely be discussed with the prescribing physician.
While generally well tolerated, CBD can nevertheless cause side effects, particularly in cases of high dosage or individual sensitivity.
The most frequently reported side effects include:
Drowsiness
Fatigue
Dry mouth
Digestive problems
Decreased appetite
Drowsiness is the most frequently observed side effect, particularly in cases of overdose.
It is therefore strongly advised against driving a vehicle or operating machinery after consuming CBD, especially during the first few uses or if a feeling of fatigue occurs.
Caution is essential, even though CBD is not classified as a narcotic.
Some users may experience:
Abdominal cramps
Diarrhea
Nausea
Vomiting
These effects are generally transient and related to an inappropriate dosage or individual sensitivity.
A decrease in appetite may be observed in some people, which may lead to slight weight loss.
One often overlooked point concerns the risk of a positive THC test during a roadside check.
Some CBD products, particularly those of insufficient quality or insufficiently purified, may contain traces of THC exceeding regulatory thresholds.
In the event of the detection of THC, even in small quantities, French road regulations provide for penalties, regardless of the legality of the product consumed.
It is therefore essential to choose products that:
Certified by an independent laboratory
Compliant with the legal THC limit (< 0.3%)
Sourced from reliable suppliers
Cannabidiol itself is not considered a doping substance by the World Anti-Doping Agency.
However, THC remains prohibited under anti-doping controls.
If a CBD product contains traces of THC, an athlete may test positive during a doping control, even if the product was legally marketed.
Vigilance is therefore particularly important for athletes subject to regular testing.
It is recommended to seek the advice of a doctor or pharmacist in the following cases:
Ongoing drug treatment
Chronic pathology
Liver failure
During pregnancy or breastfeeding
Doubt about an interaction
The healthcare professional will be able to assess the compatibility of CBD with your personal situation.
The risks associated with CBD are largely influenced by the quality of the product used.
A quality CBD product must guarantee:
A precise concentration
An absence of contaminants
Adequate purification
Complete traceability
Accessible certificates of analysis
A poorly controlled product increases the risks associated with the presence of THC or impurities.
✔ CBD is an active substance that can interact with certain medications
. ✔ Side effects are generally mild but possible.
✔ Drowsiness may occur, making driving inadvisable.
✔ Interactions exist with certain specific treatments.
✔ Product quality is essential to minimize risks.
✔ Medical advice is recommended if you are undergoing treatment or have a medical condition.
CBD consumption should always be carefully considered, tailored to your individual profile, and supervised by a healthcare professional if necessary.
Source: ameli.fr (Health Insurance)
A cannabinoid is a lipophilic molecule capable of interacting with the endocannabinoid system (ECS). Chemically, it is generally a compound derived from a terpene-phenolic ring.
Cannabinoids can be:
Phytocannabinoids (derived from the hemp plant)
Endocannabinoids (naturally produced by the body, such as anandamide or 2-AG)
Synthetic cannabinoids or neo-cannabinoids (produced through controlled laboratory processes)
Their activity depends on their molecular structure, their affinity for biological receptors, and their bioavailability.
CB1 and CB2 receptors are part of the G protein-coupled receptors (GPCR).
CB1 receptors are primarily located in the central nervous system. They are involved in the modulation of neurotransmission.
CB2 receptors are primarily expressed in the immune system and peripheral tissues.
The activation or modulation of these receptors influences various physiological mechanisms: inflammation, pain, mood, stress response, cellular homeostasis.
Not all cannabinoids act on these receptors in the same way. Some are direct agonists, others act as allosteric or indirect modulators.
THC is a partial agonist of CB1 receptors, which explains its psychoactive effect.
CBD, on the other hand:
Has a low direct affinity for CB1 and CB2
Acts as an indirect modulator of the endocannabinoid system
Interacts with other biological targets (5-HT1A receptors, TRPV1, etc.)
This difference in mechanism explains why CBD does not induce a euphoric effect comparable to THC.
A neo-cannabinoid is generally a molecule derived from a natural cannabinoid, whose structure has been modified by isomerization, hydrogenation, or other controlled chemical processes.
These changes may:
Modify the affinity for CB1/CB2 receptors
Change the duration of action
Change the perceived intensity
As these molecules are recent, long-term clinical data are often limited.
Yes. The majority of cannabinoids are metabolized by the liver via the cytochrome P450 enzyme system.
This means they can:
To be transformed into active or inactive metabolites
Interact with other substances metabolized by the same enzymes
Show variations in concentration according to the individual enzyme profile
This metabolism explains the importance of caution when using concomitant medication.
Bioavailability corresponds to the proportion of active substance reaching systemic circulation.
It varies depending on the method of consumption:
Inhalation: rapid absorption, moderate to high bioavailability
Sublingual route: intermediate absorption
Oral route: lower bioavailability due to first-pass hepatic metabolism
This parameter influences the intensity and duration of the effects.
Screening tests primarily look for THC and its metabolites.
Even if a product complies with the legal THC limit, traces may be detectable depending on:
The sensitivity of the test
Frequency of use
The concentration of the product
Individual metabolism
Cannabinoids other than THC are generally not targeted by standard tests, except in specific cases.
Scientific data on emerging molecules remain limited compared to CBD.
Some preclinical or pharmacological studies exist, but:
Large-scale clinical trials are rare
The long-term effects are still insufficiently documented
Toxicological profiles may vary
This justifies a gradual and cautious approach.
A reliable product should have:
An independent laboratory analysis
A precise indication of the concentration
Compliance with the legal THC threshold
Batch traceability
The absence of residual solvents or contaminants
Manufacturer transparency is a key indicator of reliability.
CBD does not have any identified addictive potential according to current data.
For some newer molecules, the data are still insufficient to establish a complete profile.
The potential for addiction depends on:
Affinity for CB1 receptors
The psychoactive intensity
Frequency of use
Moderate and supervised consumption limits the risks.
Responsible consumption is based on:
A low-dose start
A gradual increase if necessary
The absence of driving after use
A medical consultation in case of illness or treatment
Regular regulatory monitoring
The world of cannabinoids is evolving rapidly, both scientifically and legally. Up-to-date information and constant vigilance are essential.
Di Marzo, V., & Piscitelli, F. (2015). The Endocannabinoid System and its Modulation by Phytocannabinoids. Neurotherapeutics, 12 (4), 692–698.
https://doi.org/10.1007/s13311-015-0374-6
Lu, H.C., & Mackie, K. (2016). An Introduction to the Endogenous Cannabinoid System. Biological Psychiatry, 79 (7), 516–525.
https://doi.org/10.1016/j.biopsych.2015.07.028
Pertwee, R.G. (2008). The diverse CB1 and CB2 receptor pharmacology of cannabinoids. British Journal of Pharmacology, 153 (2), 199–215.
https://doi.org/10.1038/sj.bjp.0707442
World Health Organization (WHO). (2018). Cannabidiol (CBD) Critical Review Report . Expert Committee on Drug Dependence, 40th Meeting.
Iffland, K., & Grotenhermen, F. (2017). An update on safety and side effects of cannabidiol: A review of clinical data and relevant animal studies. Cannabis and Cannabinoid Research, 2 (1), 139–154.
https://doi.org/10.1089/can.2016.0034
Campos, AC, Moreira, FA, Gomes, FV, Del Bel, EA, & Guimarães, FS (2012). Multiple mechanisms involved in the broad-spectrum therapeutic potential of cannabidiol. Philosophical Transactions of the Royal Society B, 367 (1607), 3364–3378.
https://doi.org/10.1098/rstb.2011.0389
Zendulka, O., Dovrtělová, G., Nosková, K., Turjap, M., Šulcová, A., Hanuš, L., & Juřica, J. (2016). Cannabinoids and Cytochrome P450 Interactions. Current Drug Metabolism, 17 (3), 206–226.
https://doi.org/10.2174/1389200217666151210142051
Stout, S.M., & Cimino, N.M. (2014). Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: A systematic review. Drug Metabolism Reviews, 46 (1), 86–95.
https://doi.org/10.3109/03602532.2013.849268
Volkow, ND, Baler, RD, Compton, WM, & Weiss, SRB (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370 (23), 2219–2227.
https://doi.org/10.1056/NEJMra1402309
National Institute on Drug Abuse (NIDA). (2020). Marijuana Research Report . US Department of Health and Human Services.
Banister, S.D., & Connor, M. (2018). The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists. Handbook of Experimental Pharmacology, 252 , 191–226.
https://doi.org/10.1007/164_2018_144
European Monitoring Center for Drugs and Drug Addiction (EMCDDA). (2022). Synthetic cannabinoids in Europe — A review . Publications Office of the European Union.
Scientific data relating to cannabinoids, particularly emerging molecules, is evolving rapidly. The publications cited above are major references for understanding:
Of the endocannabinoid system
On the pharmacology of CBD and THC
Drug interactions
Synthetic cannabinoids
Recent neo-cannabinoids still have limited scientific data, particularly regarding long-term effects.
Yes, buying and consuming CBD is legal in France, provided that the products strictly comply with current regulations.
The key issue concerns the THC (tetrahydrocannabinol) content, which must not exceed the legal limit. Since European harmonization under the Common Agricultural Policy, the applicable limit is set at 0.3% THC for authorized hemp varieties.
If this threshold is respected and if the product comes from authorized hemp varieties, its marketing and consumption are legal in France.
The regulations are based primarily on two elements:
The origin of hemp
The THC level of the final product
These two criteria are cumulative and essential.
CBD products must be derived from industrial hemp varieties listed in the official catalogue of authorized varieties in the European Union.
Industrial hemp is legally cultivated for various uses:
Textile
Cosmetic
Eating
Cannabinoid extraction
Cultivation is permitted provided that approved varieties and the regulatory THC threshold are respected.
The finished product must not contain more than 0.3% THC.
This threshold applies:
With CBD oils
To the flowers
With resins
In capsule form
To cosmetics
To other hemp derivatives
Beyond this limit, the product is considered to contain a substance classified as a narcotic.
Yes. Following several court decisions, the sale of hemp flowers and leaves containing CBD is authorized, subject to compliance with the THC threshold and approved varieties.
The Council of State suspended the administrative ban that targeted the flowers, considering that CBD could not be classified as a narcotic when it complies with legal standards.
No.
Cannabidiol (CBD) is not classified as a narcotic in France or at the European level.
Only THC is classified as a narcotic substance. The legal distinction is clear and is based on the nature of the molecule and its concentration.
In 2020, the Court of Justice of the European Union (CJEU) issued a major ruling in the so-called “Kanavape” case.
The CJEU has ruled that a Member State cannot prohibit the marketing of CBD legally produced in another Member State, provided that it is extracted from the whole plant and complies with European standards.
This decision confirmed that CBD cannot be classified as a narcotic if it complies with the regulatory framework.
It is based on the fundamental principle of free movement of goods within the European Union.
No.
Despite the CJEU ruling, national frameworks remain partially heterogeneous.
Some countries:
They strictly apply the 0.3% threshold
Allow different thresholds
They frame the forms of marketing differently
It is therefore essential to check local regulations when purchasing or consuming in another European country.
Yes.
Buying CBD online is legal in France if:
The seller complies with the permitted THC threshold
The products come from approved varieties
The legal information is clearly indicated
The transparency of the site (analysis certificates, traceability, legal notices) is an important criterion.
If the product complies with the legal framework, the consumer is not committing any offense.
However, it should be noted:
In the event of a roadside check, the mere presence of THC can constitute an offense, even if the product was legal.
A poor quality product can exceed the permitted threshold without the consumer being aware of it.
Hence the importance of choosing products that have been inspected and analyzed.
To legally purchase CBD in France, it is recommended to:
Check that the product is made from European industrial hemp
Control the THC level (< 0.3%)
View the certificates of analysis
Choose transparent, specialist shops
Avoid abnormally low offers
Legal compliance rests as much on the manufacturer as on the distributor.
Yes.
The hemp and cannabinoid market is evolving rapidly, and authorities can adapt the rules accordingly:
Court decisions
Health recommendations
European developments
It is therefore recommended to stay informed regularly.
Purchasing CBD is legal in France under certain conditions.
The product must contain less than 0.3% THC.
It must be derived from authorized hemp varieties.
CBD is not classified as a narcotic.
European case law protects the free movement of compliant CBD.
This article classifies narcotic substances in France. THC is classified as a narcotic.
CBD is not.
🔗 Official text (Legifrance):
https://www.legifrance.gouv.fr/codes/article_lc/LEGIARTI000006688857
Regulates the production, possession and transfer of substances classified as narcotics.
🔗 Official text (Legifrance):
https://www.legifrance.gouv.fr/codes/article_lc/LEGIARTI000006688902
Order establishing the conditions for the cultivation, import and use of industrial hemp in France, in particular:
Authorised varieties listed in the European catalogue
Maximum THC threshold
Regulation of uses
🔗 Official text (Legifrance):
https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000044793147
Council of State, December 29, 2022, No. 444887
The Council of State has suspended the general ban on the sale of CBD flowers and leaves.
🔗 Official decision (Council of State):
https://www.conseil-etat.fr/actualites/le-conseil-d-etat-suspend-l-interdiction-de-vendre-des-fleurs-et-feuilles-brutes-de-cbd
🔗 Full decision (Legifrance):
https://www.legifrance.gouv.fr/ceta/id/CETATEXT000046795938
CJEU, 19 November 2020, Case C-663/18
The Court ruled that CBD does not constitute a narcotic and that a Member State cannot prohibit its marketing if it is legally produced in another Member State.
🔗 Official ruling (CURIA – CJEU):
https://curia.europa.eu/juris/document/document.jsf?docid=233925&doclang=FR
Regulation (EU) 2021/2115 of the European Parliament and of the Council setting, in particular, the THC threshold at 0.3% for industrial hemp.
🔗 Official text (EUR-Lex):
https://eur-lex.europa.eu/legal-content/FR/TXT/?uri=CELEX%3A32021R2115
It penalizes driving after using narcotics, regardless of the dose ingested.
🔗 Official text (Legifrance):
https://www.legifrance.gouv.fr/codes/article_lc/LEGIARTI000006842249
Confirms that the mere presence of THC is sufficient to constitute the offence, even if the product consumed is legal.
🔗 Official decision (Court of Cassation):
https://www.courdecassation.fr/decision/64927f2b4dfcf705dbd4b3a0
Purchasing CBD is legal in France if:
The product is derived from authorized varieties
The THC level is ≤ 0.3%
The national and European regulatory framework is respected
The decisions of the Council of State and the CJEU have consolidated this legal framework.
Cannabidiol (CBD) is now available in many forms to suit individual preferences and needs. All products legally sold in France must be derived from authorized hemp varieties and comply with the regulatory THC threshold (≤ 0.3%).
Here are the main categories of CBD-based products.
CBD products are generally available in the following forms:
CBD flowers
CBD resins
CBD Oils
Infusions and herbal teas
Capsules and softgels
Gummies and confectionery
CBD food products
Pet products
CBD cosmetics
E-liquids and vape formats
Each format has specific characteristics in terms of use, concentration and mode of absorption.
CBD flowers come from industrial hemp authorized for cultivation in the European Union. They naturally contain cannabidiol and other cannabinoids in varying quantities.
There are three main cultivation methods:
Outdoor (outdoor cultivation)
Indoor (indoor cultivation under a controlled environment)
Greenhouse (greenhouse cultivation)
These methods influence:
Flower density
The aromatic profile (terpenes)
Visual appearance
Cannabinoid concentration
The flowers are valued for their aromatic richness and natural profile.
CBD oil is one of the most common formats. It is obtained by extracting cannabidiol and then diluting it in a carrier oil (often MCT oil or hemp seed oil).
The main distinctions are:
Full Spectrum oils (including all the cannabinoids of the plant, within the legal limit of THC)
Broad Spectrum oils (without detectable THC)
CBD isolate-based oils (purified CBD)
The oil is usually administered sublingually.
CBD infusions or herbal teas are made from dried hemp combined with aromatic plants.
They allow for oral consumption. Being fat-soluble, CBD generally requires the addition of a fatty substance to optimize its absorption.
Infusions are chosen for their gentle and gradual approach.
CBD capsules contain a pre-defined dose of cannabidiol, allowing for precise and discreet dosing.
They offer several advantages:
Ease of use
No hemp taste
Convenient transport
Standardized dosage
Some formulas may include other ingredients (e.g., melatonin in sleep formulas).
Gummies are confectionery containing a defined amount of CBD.
They allow:
A simple plug
Discreet consumption
An alternative for people who don't like the natural taste of hemp
As with any edible product, the dosage must be respected.
Yes, subject to compliance with the regulations applicable to foodstuffs and “novel foods” at European level.
These include:
CBD chocolates
Infused drinks
Cannabidiol-enriched products
Regulatory compliance depends on the formulation and status of the CBD used.
There are CBD oils formulated specifically for dogs and cats.
Animals also possess an endocannabinoid system. However:
THC is toxic to animals
The products must be specifically formulated for veterinary use
Veterinary advice is recommended before use
These products are generally offered as broad-spectrum oils with no detectable THC.
Yes. CBD is also used in cosmetic products:
Creams
Balms
Serums
Skin oils
In this context, cannabidiol is used as a cosmetic ingredient in accordance with Regulation (EC) No 1223/2009 on cosmetic products.
CBD e-liquids are permitted in France subject to the following conditions:
Respecting the legal THC threshold
Compliance with applicable standards for electronic cigarette liquids
They are intended for use with compatible devices.
The choice depends on several criteria:
Consumer preference
Desired dosage
Desired speed of action
Individual tolerance
Context of use
It is advisable to:
Start with a low dose
Check for the presence of laboratory analyses
Ensuring regulatory compliance
No.
The effects vary depending on:
CBD concentration
The presence of other cannabinoids
The method of administration
Individual metabolism
Bioavailability differs depending on whether it is inhaled, ingested or applied to the skin.
Reputable products must be accompanied by independent laboratory analyses indicating:
CBD concentration
The THC level
The absence of contaminants
Traceability and transparency are essential criteria.
CBD products come in many forms: flowers, oils, infusions, capsules, gummies, food products, cosmetics and formulas for animals.
Their sale is legal in France if:
They come from authorized varieties
They comply with the THC threshold ≤ 0.3%
They comply with applicable sector regulations
| Product type | Method of administration | Estimated bioavailability* | Average response time | Approximate duration of action | Precise dosage | Discretion | Recommended user profile | Special Features |
|---|---|---|---|---|---|---|---|---|
| CBD flowers | Inhalation (vaporization) | Moderate to high | Quick (a few minutes) | 1 to 3 hours | Variable | Average | Users seeking rapid perception and a complete aromatic experience | Terpene-rich profile |
| CBD Resins | Inhalation (vaporization) | Moderate to high | Fast | 1 to 3 hours | Variable | Average | Experienced users who appreciate concentrated textures and intense profiles | Dense texture, high concentration |
| CBD oils (sublingual) | Sublingual route | Intermediate | 15 to 45 minutes | 4 to 6 hours | Yes | High | Beginners and regular users wanting adjustable and controlled dosage | Precise adjustment of the drops |
| CBD oils (oral) | Ingestion | Low to moderate | 30 to 90 minutes | 4 to 8 hours | Yes | High | Users seeking gradual and prolonged distribution | Liver metabolism |
| CBD infusions | Ingestion | Low to moderate | 30 to 60 minutes | 3 to 6 hours | Variable | High | People who prefer a gentle and natural approach | Requires oil for better absorption |
| Capsules | Ingestion | Low to moderate | 30 to 90 minutes | 6 to 8 hours | Yes (pre-dosed) | Very high | Users who want simplicity, precision and no taste | Standardized format |
| Gummies / Sweets | Ingestion | Low to moderate | 30 to 90 minutes | 4 to 8 hours | Yes (pre-dosed) | Very high | Users looking for a tasty alternative | Fun format |
| CBD e-liquids | Inhalation (vaping) | Moderate to high | Very fast | 1 to 3 hours | Variable | High | Users accustomed to vaping who want a quick effect | Requires compatible hardware |
| CBD cartridges | Inhalation | Moderate to high | Very fast | 1 to 3 hours | Variable | Very high | Mobile users who prioritize convenience and speed | Compact, ready-to-use format |
| CBD Cosmetics | Skin application | Local | Variable | Local | Variable | Total | People looking for a targeted and local application | For external use only |
| CBD for animals (oil) | Oral route | Intermediate | 20 to 60 minutes | 4 to 8 hours | Yes | High | Owners wishing for a product tailored to the specific needs of their pet (after veterinary consultation) | A suitable formula with no detectable THC |
*Data is indicative and may vary depending on concentration, individual metabolism and product quality.
contact@vibecity.fr
09 82 01 06 86
Monday: 12pm-8pm
Tuesday – Saturday: 10am-8pm
At Vibe City , discover a rigorous selection of CBD and cannabinoid products from controlled crops in France and Europe (Italy, Netherlands).
Each CBD flower, resin, oil or extract is chosen for its superior quality, aromatic profile and purity.
All our products strictly comply with European regulations with a THC level of less than 0.3%, guaranteeing 100% legal CBD in France .
You thus benefit from a natural, laboratory-tested CBD, designed for your daily well-being, with total transparency and compliance.
Buying CBD online should be simple and reassuring. At Vibe City CBD Shop , we use highly secure payment solutions to protect your personal and banking information.
Encrypted transactions, enhanced security protocols and trusted partners: everything is in place to guarantee a secure CBD purchase.
You can order your CBD flowers, resins or cannabinoids with complete peace of mind, without compromising on confidentiality.
Your order is carefully prepared and shipped quickly within 24 to 72 hours.
Our packages are neutral, discreet and perfectly secure to protect your privacy.
Whether you are buying premium CBD flowers, concentrated oils or next generation cannabinoids, you benefit from fast delivery throughout France and Europe .
Reliability, speed and discretion are integral parts of the Vibe City experience.
With Vibe City , buying legal CBD becomes a smooth and transparent experience. Our team selects compliant, potent, and high-quality products to meet the expectations of discerning consumers.
We are committed to offering:
Trust a reliable CBD shop in France to access the best CBD products on the market, with complete peace of mind.
